东诚药业 (002675)

Yantai Dongcheng Biochemicals Co.,Ltd.

ASZ

Tags

Contract Research Organization (CXO)Specialized-Sophisticated-Distinctive-Innovative EnterprisesInsurance Heavy PositionsImmunotherapyInnovative DrugsPharmaceutical ManufacturingHelicobacter PyloriMargin Trading and Securities LendingSME 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 82459.57
  • Circulating A-Shares(W): 74338.40
  • Earnings Per Share(RMB): 0.1808
  • Net Assets Per Share(RMB): 5.3034
  • Operating Revenue(W RMB): 204308.86
  • Total Profit(W RMB): 18166.53
  • Net Profit Attributable to Parent(W RMB): 14911.59
  • Net Profit Growth Rate(%): -10.64
  • Weighted Return on Equity(%): 3.3700
  • Operating Cash Flow Per Share(RMB): 0.4140
  • Undistributed Profit Per Share(RMB): 1.8044
  • Capital Reserve Per Share(RMB): 2.1476

2. Main Business

The main business covers:

  • Radiopharmaceutical full-chain industry
  • Production and sales of anticoagulant heparin APIs and their downstream preparations

3. Company Basic Information

  • Company Name: Yantai Dongcheng Pharmaceutical Group Co., Ltd.
  • Listing Date: 2012-05-25
  • Industry: Pharmaceutical Manufacturing
  • Address: No.7 Changbaishan Road, Yantai Economic and Technological Development Zone, Shandong Province
  • Website: www.dcb-group.com
  • Company Profile: The predecessor of the company, Yantai Dongcheng Biochemical Co., Ltd., was established on December 31, 1998. On December 27, 2007, with the approval of the Ministry of Commerce of the People's Republic of China (Document No. Shang Zi Pi [2007]2009), Yantai Dongcheng Biochemical Co., Ltd. was restructured into a foreign-invested joint-stock company through overall change. This overall change was based on the net assets of Dongcheng Co., Ltd. as of July 31, 2007, audited by Tianhengxin Accounting Firm, amounting to RMB 49,371,996.25. It was converted into 40,000,000 shares of Dongcheng Pharmaceutical at a ratio of 1:0.8102, with the remaining RMB 9,371,996.25 included in capital reserve. All assets, liabilities, and equity of the original Dongcheng Co., Ltd. were assumed by Dongcheng Pharmaceutical. On December 27, 2007, the company was registered with the Shandong Provincial Administration for Industry and Commerce and obtained the "Business License of Enterprise Legal Person" with registration number 370600400006926. The registered capital was RMB 40 million, and the legal representative was You Shouyi.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Yantai Dongyi Bioengineering Co., Ltd. General Legal Person 12488.80 16.80
2 PACIFIC RAINBOW INTERNATIONAL,INC. General Legal Person 2765.48 3.72
3 Hong Kong Securities Clearing Company Ltd. Northbound Funds 2002.72 2.69
4 Longgong (Shanghai) Machinery Manufacturing Co., Ltd. General Legal Person 1654.62 2.23
5 Ruizhong Life Insurance Co., Ltd. - Proprietary Funds Insurance 1549.29 2.08
6 Galaxy Pharmaceutical and Health Hybrid Securities Investment Fund Class A Fund 164.60 0.22
7 Xingye Healthcare Hybrid Securities Investment Fund Class A Fund 123.49 0.17
8 Galaxy Kangle Equity Securities Investment Fund Class A Fund 63.57 0.09

5. Concept Sectors

  • Immunotherapy
  • CXO Concept
  • Helicobacter Pylori
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Heavily Held by Insurance
  • Specialized and Sophisticated SMEs
  • SME 300 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information